Popular Keywords
Pulmonary and Critical Care
Infectious Disease
Pediatrics
Geriatrics and Aging
Palliative Care
Genetics
The Journal of Clinical Medicine, 2026, Volume 15, Issue 1, Pages: 1-5
Comparison Of Immunological Effects Of Commercially Available β-Glucans
Correspondence to Author: Vaclav Vetvicka.
University of Louisville, Department of Pathology, Louisville, KY 40202, USA
Abstract:
Beta glucan belongs to the most promising natural immunomodulators. However, despite decades of intensive research, its biological activity is still not fully understood. One of the causes might be the difference between individual glucans. In this study we compare nine different commercially available glucans for their activity in phagocytosis, IL-2 production, antibody formation and cancer growth reduction. Our data clearly showed the significant differences among these glucans and further confirmed that even if most glucans have strong stimulating effects on most aspects of the immune system, it is necessary to choose the right one.
Keywords: Glucan; phagocytosis; IL-2; antibody; cancer.
Citation:
Dr.Vaclav Vetvicka, Comparison Of Immunological Effects Of Commercially Available β-Glucans. The Journal of Clinical Medicine 2026.
Journal Info
- Journal Name: The Journal of Clinical Medicine
- ISSN: 2995-6315
- DOI: 10.52338/Tjocm
- Short Name: TJOCM
- Acceptance rate: 55%
- Volume: (2025)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility